The Africa CDC warns that high mpox cases, limited diagnostics, and a high fatality rate are major challenges hampering the continent’s response as cases surge.
Africa CDC Director-General Jean Kaseya said in a Friday update that the challenges include the rapid spread of mpox to new countries and inconsistent efforts to address the disease, highlighting the need for improved coordination.
Data from the Africa CDC show that from the beginning of 2024 to Aug. 23, a total of 21,466 potential cases of mpox, formerly known as monkeypox, and 591 deaths have been reported from 13 African Union (AU) members.
The 13 AU members that have reported mpox cases so far include Burundi, Cameroon, the Central Africa Republic, the Republic of the Congo, Cote d’Ivoire, the Democratic Republic of the Congo (DRC), Gabon, Liberia, Kenya, Nigeria, Rwanda, South Africa, and Uganda, it was noted.
“The cases and deaths seen are just the tip of the iceberg, given that mpox is mostly a mild condition and due to limited surveillance, testing, contact tracing, and reporting,” Kaseya said in an update letter to African health ministers concerning the ongoing mpox outbreak in Africa.
He further warned of the high case fatality rate of mpox, which he said is mostly between 3 and 4 percent, adding that the disease’s link to HIV is also of particular concern for Africa.
According to Kaseya, several previously unaffected African countries have recently reported their first imported cases of mpox, and there is a high risk that the virus could spread beyond Africa.
“Even as I wrote this letter, Gabon has confirmed its first case, while Sierra Leone and Malawi are now testing their suspected cases,” Kaseya said.
He also warned that the fact that a negative test result in the laboratory does not mean there is no mpox epidemic.
On Aug. 13, the Africa CDC declared the ongoing mpox outbreak in Africa as a Public Health Emergency of Continental Security (PHECS), citing “the clear and present danger that the onslaught of mpox is posing to the continent.”
A day after the Africa CDC’s declaration of PHECS, the World Health Organization (WHO) also declared mpox a public health emergency of international concern, activating its highest level of global alert for mpox for the second time in two years.
Kaseya said the AU’s specialized healthcare agency, in declaring the PHECS, has consulted “African best epidemiologists and lab experts” as well as international experts and appropriate bodies, including the China CDC, U.S. CDC, European CDC, and the WHO.
“The conclusion is that relying solely on laboratory test results for diagnosing mpox is not advisable. We need a holistic approach that integrates laboratory testing with clinical assessment and epidemiological data that is essential for accurately diagnosing and managing mpox. The diagnosis and management of mpox should involve a comprehensive approach,” he said.
Last week, the Africa CDC disclosed that mpox vaccination could start “in the coming days” as the number of cases surges across the continent.
The Africa CDC chief said by working closely with African countries, the WHO, and various partners, as well as by leveraging the AU’s political, policy, and advocacy capacities in responding to the outbreak, the agency is supporting African countries in their preparedness and response activities.
He further disclosed that the Africa CDC is deploying around 200 epidemiologists and logisticians in all mpox-affected African countries. This is against the backdrop of the deployment of 24 experts to support the response in the DRC and other most affected countries.
Noting that a continental strategy for mpox was developed to mobilize resources and coordinate the outbreak response, Kaseya said an incident management team was established under the leadership of the Africa CDC.
– By Xinhua
Email your news TIPS to Editor@nairobilawmonthly.com, and to advertise with us, call +254715061658 anytime of the day
